GlaxoSmithKline Aandeel

19,09EUR -0,03EUR -0,14%
<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

GlaxoSmithKline Grafiek - 1 Jaar - XETRA

Taxaties voor GlaxoSmithKline

KPI 2018 2019e 2020e 2021e 2022e
Dividend 0,80 0,80 0,80 0,81 0,82
Dividendrendement (in %) 5,34 4,92 4,92 4,96 5,03
K/W-verhouding 12,55 14,14 13,88 13,06 11,94
Winst/Aandeel 1,19 1,15 1,17 1,25 1,36
Meer nieuws

Analisten over GlaxoSmithKline plc (GSK)

1-10-2019 GlaxoSmithKline Neutral Credit Suisse Group
1-10-2019 GlaxoSmithKline Buy HSBC
30-9-2019 GlaxoSmithKline Hold Deutsche Bank AG
30-9-2019 GlaxoSmithKline Buy Jefferies & Company Inc.
27-9-2019 GlaxoSmithKline Buy Goldman Sachs Group Inc.
meer analisten

GlaxoSmithKline Peer Group

Abbott Laboratories 81,78
-0,2%
Alexion Pharmaceuticals 99,51
-5,1%
Allergan 0,00
0,0%
Bayer 66,58
0,3%
Celgene 100,97
0,0%
Gilead Sciences 65,35
0,1%
GlaxoSmithKline 16,50
-0,4%
Johnson & Johnson 135,17
1,8%
Merck 84,45
-0,7%
Merck 105,89
0,6%
Novartis 86,40
0,1%
Perrigo Company 0,00
0,0%
Pfizer 36,34
-0,4%
Roche 283,60
-1,4%
STADA 87,20
-0,1%
Sanofi 82,68
0,3%
Teva Pharmaceutical Industries 6,95
-0,3%
Vertex Pharmaceuticals 176,09
0,0%
Warner Chilcott 0,00
0,0%
pagehit

Invoer toevoegen

Wat denkt u?

Profiel GlaxoSmithKline plc (GSK)naar bedrijfsprofiel

GlaxoSmithKline Plc is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Realtime koers GlaxoSmithKline plc (GSK)

Bid
16,39 
GBP
Ask
16,43 
GBP
Tijd
17:29 
Beurs CHX

Aandelenkoers GlaxoSmithKline plc (GSK) in EURPush activeren

Koers 19,09 EUR -0,03 -0,14 %
Tijd 17:35:39
Handelsdatum 16.10.2019
Opening 19,24
Slot 19,09
Hoogste 19,39
Laagste 18,94
52 W. Hoog 19,84
52 W. Laag 15,98
52 W. Perf.
Volume (Aantal) 26.147
Marktkap. (EUR) 95,62 Mrd
Beurs

Naar aandeel GlaxoSmithKline

GlaxoSmithKline Kerncijfers

Marktkapitalisatie in Euro 95,62 Mrd
Vrij verhandelbaar in %
Aantal Aandelen 4.988,72
Kasstroom/Aandeel in lokale valuta 1,58
Boekwaarde/Aandeel in lokale valuta 0,89
60 Dagen Volatiliteit 16,84
K/B verhouding

GlaxoSmithKline Historische koersen

16-10-2019 19,09 26.147
15-10-2019 19,11 24.909
14-10-2019 19,23 24.392
11-10-2019 19,24 41.994
10-10-2019 19,22 17.219